(Q34546077)
Statements
1 reference
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer (English)
1 reference
M E R O'Brien
1 reference
N Wigler
1 reference
M Inbar
1 reference
R Rosso
1 reference
E Grischke
1 reference
A Santoro
1 reference
R Catane
1 reference
D G Kieback
1 reference
P Tomczak
1 reference
S P Ackland
1 reference
F Orlandi
1 reference
L Mellars
1 reference
L Alland
1 reference
C Tendler
1 reference
CAELYX Breast Cancer Study Group
1 reference
1 March 2004
1 reference
1 reference
15
1 reference
3
1 reference
440-449
1 reference
Identifiers
1 reference
1 reference